Industry
Merz Aesthetics Inc.
Total Trials
6
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed trials have results
Key Signals
1 recruiting2 with results
Enrollment Performance
Analytics
Phase 4
2(50.0%)
N/A
1(25.0%)
Phase 2
1(25.0%)
4Total
Phase 4(2)
N/A(1)
Phase 2(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT07419854Phase 4Recruiting
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse
Role: collaborator
NCT05456087Phase 2Active Not Recruiting
Use of Botulinum Toxin in the Treatment of Androgenic Alopecia
Role: collaborator
NCT01225354Phase 4Completed
Injectable Filler for Cheek Flattening
Role: collaborator
NCT03347747Unknown
Facial Asymmetrical Clinical Evaluation Study
Role: collaborator
NCT01832090Not ApplicableCompleted
Evaluation of Radiesse® Dermal Filler for Hand Treatment
Role: collaborator
NCT02626598Unknown
A Study Evaluating Blended Belotero for the Treatment of Etched-in Fine Facial Lines
Role: collaborator
All 6 trials loaded